LobbyingCare New England lobbying by quarter
Care New England's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q1 2023; the issues it reports most are Health Issues and Medicare/Medicaid.
Care New England
- Latest quarter
- $0
- Q2 2026 · 1 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q2 2026 against the quarter before
- First report
- Q1 2023
- The first quarter a report named it
Lobbying by quarter
No lobbying spend in this period.
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2023 | $0 | 1 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
Policy issues the reports name
- Health issues9 reports
- Medicare and Medicaid7 reports
- Budget and appropriations2 reports
- Pharmacy1 reports
A report that names several issues counts once for each.
Who was lobbied
- SENATE7 reports
- HOUSE OF REPRESENTATIVES6 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseCare New England | $0 | 14 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 08/11for Q2 | In-house | Under $5,000 |
| 04/15for Q1 | In-house | Under $5,000 |
| 01/06for Q4 2025 | In-house | Under $5,000 |
| 25/10/12for Q3 2025 | In-house | Under $5,000 |
| 25/07/02for Q2 2025 | In-house | Under $5,000 |
| 25/04/14for Q1 2025 | In-house | Under $5,000 |
| 25/01/10for Q4 2024 | In-house | Under $5,000 |
| 24/10/11for Q3 2024 | In-house | Under $5,000 |
| 24/08/19for Q2 2024 | In-house | Under $5,000 |
| 24/07/18for Q2 2024 | In-house | Under $5,000 |
| 24/04/01for Q1 2024 | In-house | Under $5,000 |
| 24/02/05for Q4 2023 | In-house | Under $5,000 |
| 24/01/24for Q1 2023 | In-house | Under $5,000 |
| 24/01/24for Q2 2023 | In-house | Under $5,000 |
| 24/01/24for Q3 2023 | In-house | Under $5,000 |
| 24/01/21for Q1 2023 | In-house | Under $5,000 |